GO:1902600 | proton transmembrane transport | 10.64% (5/47) | 6.32 | 0.0 | 1e-06 |
GO:0098660 | inorganic ion transmembrane transport | 10.64% (5/47) | 5.56 | 0.0 | 1e-06 |
GO:0098662 | inorganic cation transmembrane transport | 10.64% (5/47) | 5.56 | 0.0 | 1e-06 |
GO:0009141 | nucleoside triphosphate metabolic process | 10.64% (5/47) | 5.56 | 0.0 | 1e-06 |
GO:0098655 | cation transmembrane transport | 10.64% (5/47) | 5.56 | 0.0 | 1e-06 |
GO:0034220 | ion transmembrane transport | 10.64% (5/47) | 5.47 | 0.0 | 1e-06 |
GO:0009126 | purine nucleoside monophosphate metabolic process | 10.64% (5/47) | 5.58 | 0.0 | 2e-06 |
GO:0009123 | nucleoside monophosphate metabolic process | 10.64% (5/47) | 5.58 | 0.0 | 2e-06 |
GO:0009167 | purine ribonucleoside monophosphate metabolic process | 10.64% (5/47) | 5.58 | 0.0 | 2e-06 |
GO:0009161 | ribonucleoside monophosphate metabolic process | 10.64% (5/47) | 5.58 | 0.0 | 2e-06 |
GO:0009205 | purine ribonucleoside triphosphate metabolic process | 10.64% (5/47) | 5.63 | 0.0 | 2e-06 |
GO:0009199 | ribonucleoside triphosphate metabolic process | 10.64% (5/47) | 5.63 | 0.0 | 2e-06 |
GO:0009144 | purine nucleoside triphosphate metabolic process | 10.64% (5/47) | 5.63 | 0.0 | 2e-06 |
GO:0046034 | ATP metabolic process | 10.64% (5/47) | 5.64 | 0.0 | 4e-06 |
GO:0015672 | monovalent inorganic cation transport | 10.64% (5/47) | 5.64 | 0.0 | 4e-06 |
GO:0006163 | purine nucleotide metabolic process | 10.64% (5/47) | 5.12 | 0.0 | 4e-06 |
GO:0009150 | purine ribonucleotide metabolic process | 10.64% (5/47) | 5.14 | 0.0 | 4e-06 |
GO:0009259 | ribonucleotide metabolic process | 10.64% (5/47) | 5.14 | 0.0 | 4e-06 |
GO:0072521 | purine-containing compound metabolic process | 10.64% (5/47) | 5.1 | 0.0 | 4e-06 |
GO:0019693 | ribose phosphate metabolic process | 10.64% (5/47) | 5.08 | 0.0 | 4e-06 |
GO:0009117 | nucleotide metabolic process | 10.64% (5/47) | 4.91 | 1e-06 | 7e-06 |
GO:0006753 | nucleoside phosphate metabolic process | 10.64% (5/47) | 4.87 | 1e-06 | 8e-06 |
GO:0055086 | nucleobase-containing small molecule metabolic process | 10.64% (5/47) | 4.7 | 1e-06 | 1.4e-05 |
GO:0017144 | drug metabolic process | 10.64% (5/47) | 4.65 | 2e-06 | 1.5e-05 |
GO:0019637 | organophosphate metabolic process | 10.64% (5/47) | 4.45 | 3e-06 | 2.9e-05 |
GO:1901135 | carbohydrate derivative metabolic process | 10.64% (5/47) | 4.42 | 4e-06 | 3.2e-05 |
GO:0006812 | cation transport | 10.64% (5/47) | 4.34 | 5e-06 | 3.9e-05 |
GO:0006811 | ion transport | 10.64% (5/47) | 3.89 | 2.2e-05 | 0.000172 |
GO:0044281 | small molecule metabolic process | 10.64% (5/47) | 3.18 | 0.000221 | 0.001647 |
GO:0006139 | nucleobase-containing compound metabolic process | 12.77% (6/47) | 2.71 | 0.000298 | 0.002147 |
GO:0046483 | heterocycle metabolic process | 12.77% (6/47) | 2.6 | 0.000447 | 0.003112 |
GO:0006725 | cellular aromatic compound metabolic process | 12.77% (6/47) | 2.57 | 0.000494 | 0.003338 |
GO:1901360 | organic cyclic compound metabolic process | 12.77% (6/47) | 2.53 | 0.000562 | 0.00368 |
GO:0015985 | energy coupled proton transport, down electrochemical gradient | 4.26% (2/47) | 5.78 | 0.000615 | 0.003795 |
GO:0015986 | ATP synthesis coupled proton transport | 4.26% (2/47) | 5.78 | 0.000615 | 0.003795 |
GO:0051234 | establishment of localization | 12.77% (6/47) | 2.45 | 0.000747 | 0.004361 |
GO:0051179 | localization | 12.77% (6/47) | 2.44 | 0.00078 | 0.004432 |
GO:0006810 | transport | 12.77% (6/47) | 2.46 | 0.000743 | 0.004458 |
GO:0055085 | transmembrane transport | 10.64% (5/47) | 2.77 | 0.000816 | 0.004517 |
GO:0034641 | cellular nitrogen compound metabolic process | 12.77% (6/47) | 2.29 | 0.001323 | 0.007145 |
GO:0006754 | ATP biosynthetic process | 4.26% (2/47) | 4.49 | 0.003601 | 0.017285 |
GO:0009201 | ribonucleoside triphosphate biosynthetic process | 4.26% (2/47) | 4.49 | 0.003601 | 0.017285 |
GO:0009142 | nucleoside triphosphate biosynthetic process | 4.26% (2/47) | 4.49 | 0.003601 | 0.017285 |
GO:0009206 | purine ribonucleoside triphosphate biosynthetic process | 4.26% (2/47) | 4.49 | 0.003601 | 0.017285 |
GO:0009145 | purine nucleoside triphosphate biosynthetic process | 4.26% (2/47) | 4.49 | 0.003601 | 0.017285 |
GO:0009127 | purine nucleoside monophosphate biosynthetic process | 4.26% (2/47) | 4.42 | 0.003971 | 0.017504 |
GO:0009156 | ribonucleoside monophosphate biosynthetic process | 4.26% (2/47) | 4.42 | 0.003971 | 0.017504 |
GO:0009124 | nucleoside monophosphate biosynthetic process | 4.26% (2/47) | 4.42 | 0.003971 | 0.017504 |
GO:0009168 | purine ribonucleoside monophosphate biosynthetic process | 4.26% (2/47) | 4.42 | 0.003971 | 0.017504 |
GO:0046390 | ribose phosphate biosynthetic process | 4.26% (2/47) | 4.37 | 0.004259 | 0.017692 |
GO:0009152 | purine ribonucleotide biosynthetic process | 4.26% (2/47) | 4.37 | 0.004259 | 0.017692 |
GO:0009260 | ribonucleotide biosynthetic process | 4.26% (2/47) | 4.37 | 0.004259 | 0.017692 |
GO:0006164 | purine nucleotide biosynthetic process | 4.26% (2/47) | 4.35 | 0.004358 | 0.017759 |
GO:0072522 | purine-containing compound biosynthetic process | 4.26% (2/47) | 4.32 | 0.004557 | 0.018229 |
GO:0030942 | endoplasmic reticulum signal peptide binding | 2.13% (1/47) | 7.46 | 0.005676 | 0.02151 |
GO:0005047 | signal recognition particle binding | 2.13% (1/47) | 7.46 | 0.005676 | 0.02151 |
GO:0005786 | signal recognition particle, endoplasmic reticulum targeting | 2.13% (1/47) | 7.46 | 0.005676 | 0.02151 |
GO:0009165 | nucleotide biosynthetic process | 4.26% (2/47) | 4.12 | 0.005956 | 0.021804 |
GO:1901293 | nucleoside phosphate biosynthetic process | 4.26% (2/47) | 4.12 | 0.005956 | 0.021804 |
GO:1901137 | carbohydrate derivative biosynthetic process | 4.26% (2/47) | 4.02 | 0.00678 | 0.024408 |
GO:0005048 | signal sequence binding | 2.13% (1/47) | 6.97 | 0.007938 | 0.027654 |
GO:0042277 | peptide binding | 2.13% (1/47) | 6.97 | 0.007938 | 0.027654 |
GO:0008312 | 7S RNA binding | 2.13% (1/47) | 6.78 | 0.009067 | 0.03013 |
GO:0048500 | signal recognition particle | 2.13% (1/47) | 6.78 | 0.009067 | 0.03013 |
GO:0005730 | nucleolus | 2.13% (1/47) | 6.78 | 0.009067 | 0.03013 |
GO:0090407 | organophosphate biosynthetic process | 4.26% (2/47) | 3.71 | 0.010263 | 0.033085 |
GO:0008134 | transcription factor binding | 2.13% (1/47) | 6.61 | 0.010194 | 0.033363 |
GO:0043021 | ribonucleoprotein complex binding | 2.13% (1/47) | 6.46 | 0.011321 | 0.03596 |
GO:0016168 | chlorophyll binding | 2.13% (1/47) | 6.32 | 0.012446 | 0.038961 |
GO:0006612 | protein targeting to membrane | 2.13% (1/47) | 6.19 | 0.01357 | 0.039081 |
GO:0006614 | SRP-dependent cotranslational protein targeting to membrane | 2.13% (1/47) | 6.19 | 0.01357 | 0.039081 |
GO:0070972 | protein localization to endoplasmic reticulum | 2.13% (1/47) | 6.19 | 0.01357 | 0.039081 |
GO:0006613 | cotranslational protein targeting to membrane | 2.13% (1/47) | 6.19 | 0.01357 | 0.039081 |
GO:0072599 | establishment of protein localization to endoplasmic reticulum | 2.13% (1/47) | 6.19 | 0.01357 | 0.039081 |
GO:0045047 | protein targeting to ER | 2.13% (1/47) | 6.19 | 0.01357 | 0.039081 |
GO:0090150 | establishment of protein localization to membrane | 2.13% (1/47) | 6.08 | 0.014693 | 0.041215 |
GO:0072657 | protein localization to membrane | 2.13% (1/47) | 6.08 | 0.014693 | 0.041215 |
GO:0033218 | amide binding | 2.13% (1/47) | 5.97 | 0.015814 | 0.043238 |
GO:0044877 | protein-containing complex binding | 2.13% (1/47) | 5.97 | 0.015814 | 0.043238 |
GO:0006796 | phosphate-containing compound metabolic process | 10.64% (5/47) | 1.74 | 0.016617 | 0.044313 |
GO:0006793 | phosphorus metabolic process | 10.64% (5/47) | 1.74 | 0.016617 | 0.044313 |
GO:0044424 | intracellular part | 8.51% (4/47) | 1.98 | 0.018488 | 0.048699 |
GO:0006605 | protein targeting | 2.13% (1/47) | 5.69 | 0.019171 | 0.04989 |